HUTCHMED (China) Limited (AIM: HCM)
London
· Delayed Price · Currency is GBP · Price in GBX
273.00
+4.00 (1.49%)
Dec 2, 2024, 10:15 AM GMT+1
HUTCHMED (China) Employees
HUTCHMED (China) had 1,988 employees as of December 31, 2023. The number of employees decreased by 37 or -1.83% compared to the previous year.
Employees
1,988
Change (1Y)
-37
Growth (1Y)
-1.83%
Revenue / Employee
245.34K GBP
Profits / Employee
-16.86K GBP
Market Cap
2.39B
Employees Chart
HUTCHMED (China) News
- 11 days ago - HUTCHMED Announces Launch by Takeda of FRUZAQLA® (fruquintinib) in Japan - GlobeNewsWire
- 13 days ago - HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee - GlobeNewsWire
- 27 days ago - HUTCHMED Highlights Clinical Data to be Presented at the 2024 ASH Annual Meeting and the 2024 ESMO Asia Congress - GlobeNewsWire
- 4 weeks ago - HUTCHMED to Receive First Commercial Milestone Payment Following Over US$200 Million in FRUZAQLA® (fruquintinib) Sales by Takeda - GlobeNewsWire
- 6 weeks ago - HUTCHMED Announces that TAGRISSO® plus ORPATHYS® demonstrated high, clinically meaningful response rate in lung cancer patients with high levels of MET overexpression and/or amplification in SAVANNAH Phase II trial - GlobeNewsWire
- 2 months ago - HUTCHMED (China) Ltd (HCM) Shares Up 2.9% on Oct 2 - GuruFocus
- 2 months ago - HUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by Takeda - GlobeNewsWire
- 2 months ago - International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024 - Benzinga